- $80.28m
- -$102.55m
- $0.32m
- 29
- 26
- 55
- 30
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 12.5 | 5.37 | 1.98 | 33.8 | 0.324 |
Cost of Revenue | |||||
Gross Profit | — | — | — | 33.4 | 0.324 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 128 | 49.9 | 175 | -135 | 93.4 |
Operating Profit | -116 | -44.5 | -173 | 169 | -93.1 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -113 | -43.5 | -173 | 172 | -82.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | -113 | -43.5 | -173 | 172 | -82.1 |
Net Income Before Extraordinary Items | |||||
Net Income | -113 | -43.5 | -173 | 172 | -82.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -113 | -43.5 | -173 | 172 | -82.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.758 | -0.7 | -1.06 | 0.258 | -0.927 |